B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 600 KRW -2.13% Market Closed
Market Cap: 469.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioNote Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Additional Paid In Capital
â‚©82.7B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Additional Paid In Capital
â‚©14.8T
CAGR 3-Years
159%
CAGR 5-Years
79%
CAGR 10-Years
44%
SK Bioscience Co Ltd
KRX:302440
Additional Paid In Capital
â‚©1.2T
CAGR 3-Years
86%
CAGR 5-Years
42%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Additional Paid In Capital
â‚©394.5B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Additional Paid In Capital
â‚©180.6B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Additional Paid In Capital
â‚©121.7B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
469.5B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
6 138.02 KRW
Undervaluation 25%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Additional Paid In Capital?
Additional Paid In Capital
82.7B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Additional Paid In Capital amounts to 82.7B KRW.

What is BioNote Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
14%

Over the last year, the Additional Paid In Capital growth was 2%. The average annual Additional Paid In Capital growth rates for BioNote Inc have been 14% over the past three years .

Back to Top